bpc 157 subcutaneous dose bpc-157 dosing protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved bpc 157 subcutaneous injection dosage
Description
Ask your teams compliance or medical staff and check the governing bodys list

Choosing a different effect will add another unique element to this graphic

Copper overload is a theoretical concern with copper peptide injections at high GHK-Cu doses, since copper is a mineral the body tightly controls

X: @kimberlylimmy

Any aggressive fat-loss protocol carries a risk of dropping lean mass along with fat
